Biogen, Inc. (BIIB)
197.20
+4.58
(+2.38%)
USD |
NASDAQ |
Jun 09, 14:05
Biogen SG&A Expense (Quarterly) : 607.30M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 1.451B |
| AbbVie, Inc. | 3.578B |
| Amgen, Inc. | 1.602B |
| Regeneron Pharmaceuticals, Inc. | 647.70M |
| Ionis Pharmaceuticals, Inc. | 150.36M |